Back
Structure Therapeutics Vs. Amgen Industry Stock Comparison
Sell
16
GPCR
Structure Therapeutics
Last Price:
30.10
Seasonality Move:
-11.15%
Sell
38
AMGN
Amgen
Last Price:
289.88
Seasonality Move:
9.62%
Sell
16
Structure Therapeutics (GPCR)
is a Sell
Is Structure Therapeutics a Buy, Sell or Hold?
- The current Structure Therapeutics [GPCR] share price is $30.10. The Score for GPCR is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- GPCR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
38
Amgen (AMGN)
is a Sell
Is Amgen a Buy, Sell or Hold?
- The current Amgen [AMGN] share price is $289.90. The Score for AMGN is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- AMGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GPCR Stock Price Chart
What is Structure Therapeutics's stock price today?
-
The Structure Therapeutics share price today is $30.10
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing selling pressure, which indicates risk of future bearish movement.
GPCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.9 | Sell |
| Relative Strength Index (14 RSI): | 29.57 | Sell |
| Chaikin Money Flow: | -746574 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.51 - 40.09) | Sell |
| Bollinger Bands (100): | (35.63 - 41.33) | Sell |
AMGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -9.51 | Sell |
| Relative Strength Index (14 RSI): | 35.4 | Sell |
| Chaikin Money Flow: | 2143035 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (294.89 - 324.11) | Sell |
| Bollinger Bands (100): | (310.17 - 334.17) | Sell |
GPCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.06 | Sell |
| 20-day SMA: | 36.96 | Sell |
| 50-day SMA: | 38.95 | Sell |
| 200-day SMA: | 39.82 | Sell |
| 8-day EMA: | 33.62 | Sell |
| 20-day EMA: | 36 | Sell |
| 50-day EMA: | 37.78 | Sell |
| 200-day EMA: | 39.23 | Sell |
AMGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 289.54 | Buy |
| 20-day SMA: | 307.44 | Sell |
| 50-day SMA: | 317.46 | Sell |
| 200-day SMA: | 305.77 | Sell |
| 8-day EMA: | 292.01 | Sell |
| 20-day EMA: | 302.87 | Sell |
| 50-day EMA: | 312.8 | Sell |
| 200-day EMA: | 306.92 | Sell |
Structure Therapeutics Earnings Growth & GPCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.15 per share.
Amgen Earnings Growth & AMGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and an increase next year of $1.07 per share.
Structure Therapeutics Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amgen Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||